Related Experiment Video
Updated: Feb 14, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.2K
Optogenetics in cancer drug discovery
Michał Kiełbus1, Jakub Czapiński1,2, Adrian Odrzywolski1
1a Department of Biochemistry and Molecular Biology , Medical University of Lublin , Lublin , Poland.
Expert Opinion on Drug Discovery
|February 16, 2018
Summary
Optogenetic tools, which use light to control cellular behavior, offer precise methods for cancer drug discovery and research. These light-responsive biomolecules promise safer, more effective cancer therapies by enabling targeted manipulation of cellular processes.
Area of Science:
- Optogenetics
- Molecular Biology
- Cancer Research
Background:
- Current drug discovery faces challenges with drug efficacy and safety.
- Need for controllable and personalized cancer therapies.
- Light offers a safe, inexpensive, and precisely controllable modality for biological manipulation.
Purpose of the Study:
- Analyze current optogenetic tools.
- Explore their applications in cancer drug discovery, biosafety, and cancer biology.
- Highlight their potential to revolutionize cancer research and therapy.
Main Methods:
- Review and analysis of existing optogenetic tools.
- Discussion of light-responsive biomolecules and their mechanisms.
- Exploration of spatio-temporal control in cellular manipulation.
Main Results:
- Optogenetic tools provide high spatio-temporal resolution for cellular control.
- Light-responsive systems can modulate cell signaling, genome, epigenome, and cell fate.
- Potential to overcome limitations in current drug discovery pipelines.
Conclusions:
- Optogenetics presents a powerful approach for developing safer and more effective cancer drugs.
- These tools can enable personalized therapies by precisely controlling cellular events.
- Significant potential to advance cancer biology and drug discovery.
Keywords:
Optogeneticscancercell motilitydrug resistancedrug screeningdrug targetsoff-targetstoxicityMore Related Videos
Related Concept Videos
01:26Drug Discovery: Overview
12.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.0K
01:30Drug toxicity: Drug–Drug Interaction
20
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
20
02:18Cancer
54.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K
02:12What is Cancer?
14.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K
01:25Pharmacokinetics: Drug–Drug Interactions
471
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
471
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
167
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
167